Pharmalex Nordic ApS — Credit Rating and Financial Key Figures

Pharmalex Nordic ApS (CVR number: 37541540) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of 3533.8 kDKK in 2025. The operating profit was 1664 kDKK, while net earnings were 1709.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 4.2 %, which can be considered decent but Return on Equity (ROE) was 0.9 %, which can be considered weak. The equity ratio, a key indicator for solidity, stood at -18.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Pharmalex Nordic ApS's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.